0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Duchenne Muscular Dystrophy Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-12K736
Home | Market Reports | Health| Health Conditions| Genetic Disorders
Global Duchenne Muscular Dystrophy Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Duchenne Muscular Dystrophy Market Research Report 2024

Code: QYRE-Auto-12K736
Report
February 2024
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Duchenne Muscular Dystrophy Market Size

The global Duchenne Muscular Dystrophy market was valued at US$ 1203 million in 2023 and is anticipated to reach US$ 13540 million by 2030, witnessing a CAGR of 42.1% during the forecast period 2024-2030.

Duchenne Muscular Dystrophy Market

Duchenne Muscular Dystrophy Market

uchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.
Global Duchenne Muscular Dystrophy key players include Sarepta Therapeutics, PTC Therapeutics, etc.
North America is the largest market, with a share over 70%, followed by Europe, and Japan, both have a share over 25 percent.
In terms of product, Exondys 51 is the largest segment, with a share over 55%. And in terms of application, the largest application is Hospitals, followed by Clinics, Home Care, etc.
This report aims to provide a comprehensive presentation of the global market for Duchenne Muscular Dystrophy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Duchenne Muscular Dystrophy.

Report Scope

The Duchenne Muscular Dystrophy market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Duchenne Muscular Dystrophy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Duchenne Muscular Dystrophy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Duchenne Muscular Dystrophy Market Report

Report Metric Details
Report Name Duchenne Muscular Dystrophy Market
Accounted market size in 2023 US$ 1203 million
Forecasted market size in 2030 US$ 13540 million
CAGR 42.1%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Exondys 51
  • Emflaza
  • Translarna
Segment by Application
  • Hospitals
  • Clinics
  • Home Care
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sarepta Therapeutics, PTC Therapeutics, Pfizer, Bristol-Myers Squibb, Italfarmaco, Santhera Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Duchenne Muscular Dystrophy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Duchenne Muscular Dystrophy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Duchenne Muscular Dystrophy Market growing?

Ans: The Duchenne Muscular Dystrophy Market witnessing a CAGR of 42.1% during the forecast period 2024-2030.

What is the Duchenne Muscular Dystrophy Market size in 2030?

Ans: The Duchenne Muscular Dystrophy Market size in 2030 will be US$ 13540 million.

What is the Duchenne Muscular Dystrophy Market share by type?

Ans: In terms of product, Exondys 51 is the largest segment, with a share over 55%.

Who are the main players in the Duchenne Muscular Dystrophy Market report?

Ans: The main players in the Duchenne Muscular Dystrophy Market are Sarepta Therapeutics, PTC Therapeutics, Pfizer, Bristol-Myers Squibb, Italfarmaco, Santhera Pharmaceuticals

What are the Application segmentation covered in the Duchenne Muscular Dystrophy Market report?

Ans: The Applications covered in the Duchenne Muscular Dystrophy Market report are Hospitals, Clinics, Home Care

What are the Type segmentation covered in the Duchenne Muscular Dystrophy Market report?

Ans: The Types covered in the Duchenne Muscular Dystrophy Market report are Exondys 51, Emflaza, Translarna

1 Duchenne Muscular Dystrophy Market Overview
1.1 Product Overview and Scope of Duchenne Muscular Dystrophy
1.2 Duchenne Muscular Dystrophy Segment by Type
1.2.1 Global Duchenne Muscular Dystrophy Market Value Comparison by Type (2024-2030)
1.2.2 Exondys 51
1.2.3 Emflaza
1.2.4 Translarna
1.3 Duchenne Muscular Dystrophy Segment by Application
1.3.1 Global Duchenne Muscular Dystrophy Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care
1.4 Global Duchenne Muscular Dystrophy Market Size Estimates and Forecasts
1.4.1 Global Duchenne Muscular Dystrophy Revenue 2019-2030
1.4.2 Global Duchenne Muscular Dystrophy Sales 2019-2030
1.4.3 Global Duchenne Muscular Dystrophy Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Duchenne Muscular Dystrophy Market Competition by Manufacturers
2.1 Global Duchenne Muscular Dystrophy Sales Market Share by Manufacturers (2019-2024)
2.2 Global Duchenne Muscular Dystrophy Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Duchenne Muscular Dystrophy Average Price by Manufacturers (2019-2024)
2.4 Global Duchenne Muscular Dystrophy Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Duchenne Muscular Dystrophy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Duchenne Muscular Dystrophy, Product Type & Application
2.7 Duchenne Muscular Dystrophy Market Competitive Situation and Trends
2.7.1 Duchenne Muscular Dystrophy Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Duchenne Muscular Dystrophy Players Market Share by Revenue
2.7.3 Global Duchenne Muscular Dystrophy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Duchenne Muscular Dystrophy Retrospective Market Scenario by Region
3.1 Global Duchenne Muscular Dystrophy Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Duchenne Muscular Dystrophy Global Duchenne Muscular Dystrophy Sales by Region: 2019-2030
3.2.1 Global Duchenne Muscular Dystrophy Sales by Region: 2019-2024
3.2.2 Global Duchenne Muscular Dystrophy Sales by Region: 2025-2030
3.3 Global Duchenne Muscular Dystrophy Global Duchenne Muscular Dystrophy Revenue by Region: 2019-2030
3.3.1 Global Duchenne Muscular Dystrophy Revenue by Region: 2019-2024
3.3.2 Global Duchenne Muscular Dystrophy Revenue by Region: 2025-2030
3.4 North America Duchenne Muscular Dystrophy Market Facts & Figures by Country
3.4.1 North America Duchenne Muscular Dystrophy Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Duchenne Muscular Dystrophy Sales by Country (2019-2030)
3.4.3 North America Duchenne Muscular Dystrophy Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Duchenne Muscular Dystrophy Market Facts & Figures by Country
3.5.1 Europe Duchenne Muscular Dystrophy Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Duchenne Muscular Dystrophy Sales by Country (2019-2030)
3.5.3 Europe Duchenne Muscular Dystrophy Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Duchenne Muscular Dystrophy Market Facts & Figures by Country
3.6.1 Asia Pacific Duchenne Muscular Dystrophy Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Duchenne Muscular Dystrophy Sales by Country (2019-2030)
3.6.3 Asia Pacific Duchenne Muscular Dystrophy Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Duchenne Muscular Dystrophy Market Facts & Figures by Country
3.7.1 Latin America Duchenne Muscular Dystrophy Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Duchenne Muscular Dystrophy Sales by Country (2019-2030)
3.7.3 Latin America Duchenne Muscular Dystrophy Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Duchenne Muscular Dystrophy Market Facts & Figures by Country
3.8.1 Middle East and Africa Duchenne Muscular Dystrophy Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Duchenne Muscular Dystrophy Sales by Country (2019-2030)
3.8.3 Middle East and Africa Duchenne Muscular Dystrophy Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Duchenne Muscular Dystrophy Sales by Type (2019-2030)
4.1.1 Global Duchenne Muscular Dystrophy Sales by Type (2019-2024)
4.1.2 Global Duchenne Muscular Dystrophy Sales by Type (2025-2030)
4.1.3 Global Duchenne Muscular Dystrophy Sales Market Share by Type (2019-2030)
4.2 Global Duchenne Muscular Dystrophy Revenue by Type (2019-2030)
4.2.1 Global Duchenne Muscular Dystrophy Revenue by Type (2019-2024)
4.2.2 Global Duchenne Muscular Dystrophy Revenue by Type (2025-2030)
4.2.3 Global Duchenne Muscular Dystrophy Revenue Market Share by Type (2019-2030)
4.3 Global Duchenne Muscular Dystrophy Price by Type (2019-2030)
5 Segment by Application
5.1 Global Duchenne Muscular Dystrophy Sales by Application (2019-2030)
5.1.1 Global Duchenne Muscular Dystrophy Sales by Application (2019-2024)
5.1.2 Global Duchenne Muscular Dystrophy Sales by Application (2025-2030)
5.1.3 Global Duchenne Muscular Dystrophy Sales Market Share by Application (2019-2030)
5.2 Global Duchenne Muscular Dystrophy Revenue by Application (2019-2030)
5.2.1 Global Duchenne Muscular Dystrophy Revenue by Application (2019-2024)
5.2.2 Global Duchenne Muscular Dystrophy Revenue by Application (2025-2030)
5.2.3 Global Duchenne Muscular Dystrophy Revenue Market Share by Application (2019-2030)
5.3 Global Duchenne Muscular Dystrophy Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sarepta Therapeutics
6.1.1 Sarepta Therapeutics Corporation Information
6.1.2 Sarepta Therapeutics Description and Business Overview
6.1.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sarepta Therapeutics Duchenne Muscular Dystrophy Product Portfolio
6.1.5 Sarepta Therapeutics Recent Developments/Updates
6.2 PTC Therapeutics
6.2.1 PTC Therapeutics Corporation Information
6.2.2 PTC Therapeutics Description and Business Overview
6.2.3 PTC Therapeutics Duchenne Muscular Dystrophy Sales, Revenue and Gross Margin (2019-2024)
6.2.4 PTC Therapeutics Duchenne Muscular Dystrophy Product Portfolio
6.2.5 PTC Therapeutics Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Duchenne Muscular Dystrophy Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Duchenne Muscular Dystrophy Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Bristol-Myers Squibb
6.4.1 Bristol-Myers Squibb Corporation Information
6.4.2 Bristol-Myers Squibb Description and Business Overview
6.4.3 Bristol-Myers Squibb Duchenne Muscular Dystrophy Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bristol-Myers Squibb Duchenne Muscular Dystrophy Product Portfolio
6.4.5 Bristol-Myers Squibb Recent Developments/Updates
6.5 Italfarmaco
6.5.1 Italfarmaco Corporation Information
6.5.2 Italfarmaco Description and Business Overview
6.5.3 Italfarmaco Duchenne Muscular Dystrophy Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Italfarmaco Duchenne Muscular Dystrophy Product Portfolio
6.5.5 Italfarmaco Recent Developments/Updates
6.6 Santhera Pharmaceuticals
6.6.1 Santhera Pharmaceuticals Corporation Information
6.6.2 Santhera Pharmaceuticals Description and Business Overview
6.6.3 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Product Portfolio
6.6.5 Santhera Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Duchenne Muscular Dystrophy Industry Chain Analysis
7.2 Duchenne Muscular Dystrophy Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Duchenne Muscular Dystrophy Production Mode & Process
7.4 Duchenne Muscular Dystrophy Sales and Marketing
7.4.1 Duchenne Muscular Dystrophy Sales Channels
7.4.2 Duchenne Muscular Dystrophy Distributors
7.5 Duchenne Muscular Dystrophy Customers
8 Duchenne Muscular Dystrophy Market Dynamics
8.1 Duchenne Muscular Dystrophy Industry Trends
8.2 Duchenne Muscular Dystrophy Market Drivers
8.3 Duchenne Muscular Dystrophy Market Challenges
8.4 Duchenne Muscular Dystrophy Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Duchenne Muscular Dystrophy Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Duchenne Muscular Dystrophy Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Duchenne Muscular Dystrophy Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Duchenne Muscular Dystrophy Sales (K Doses) of Key Manufacturers (2019-2024)
    Table 5. Global Duchenne Muscular Dystrophy Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Duchenne Muscular Dystrophy Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Duchenne Muscular Dystrophy Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Duchenne Muscular Dystrophy Average Price (USD/Dose) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Duchenne Muscular Dystrophy, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Duchenne Muscular Dystrophy, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Duchenne Muscular Dystrophy, Product Type & Application
    Table 12. Global Key Manufacturers of Duchenne Muscular Dystrophy, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Duchenne Muscular Dystrophy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Duchenne Muscular Dystrophy as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Duchenne Muscular Dystrophy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Duchenne Muscular Dystrophy Sales by Region (2019-2024) & (K Doses)
    Table 18. Global Duchenne Muscular Dystrophy Sales Market Share by Region (2019-2024)
    Table 19. Global Duchenne Muscular Dystrophy Sales by Region (2025-2030) & (K Doses)
    Table 20. Global Duchenne Muscular Dystrophy Sales Market Share by Region (2025-2030)
    Table 21. Global Duchenne Muscular Dystrophy Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Duchenne Muscular Dystrophy Revenue Market Share by Region (2019-2024)
    Table 23. Global Duchenne Muscular Dystrophy Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Duchenne Muscular Dystrophy Revenue Market Share by Region (2025-2030)
    Table 25. North America Duchenne Muscular Dystrophy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Duchenne Muscular Dystrophy Sales by Country (2019-2024) & (K Doses)
    Table 27. North America Duchenne Muscular Dystrophy Sales by Country (2025-2030) & (K Doses)
    Table 28. North America Duchenne Muscular Dystrophy Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Duchenne Muscular Dystrophy Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Duchenne Muscular Dystrophy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Duchenne Muscular Dystrophy Sales by Country (2019-2024) & (K Doses)
    Table 32. Europe Duchenne Muscular Dystrophy Sales by Country (2025-2030) & (K Doses)
    Table 33. Europe Duchenne Muscular Dystrophy Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Duchenne Muscular Dystrophy Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Duchenne Muscular Dystrophy Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Duchenne Muscular Dystrophy Sales by Region (2019-2024) & (K Doses)
    Table 37. Asia Pacific Duchenne Muscular Dystrophy Sales by Region (2025-2030) & (K Doses)
    Table 38. Asia Pacific Duchenne Muscular Dystrophy Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Duchenne Muscular Dystrophy Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Duchenne Muscular Dystrophy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Duchenne Muscular Dystrophy Sales by Country (2019-2024) & (K Doses)
    Table 42. Latin America Duchenne Muscular Dystrophy Sales by Country (2025-2030) & (K Doses)
    Table 43. Latin America Duchenne Muscular Dystrophy Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Duchenne Muscular Dystrophy Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Duchenne Muscular Dystrophy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Duchenne Muscular Dystrophy Sales by Country (2019-2024) & (K Doses)
    Table 47. Middle East & Africa Duchenne Muscular Dystrophy Sales by Country (2025-2030) & (K Doses)
    Table 48. Middle East & Africa Duchenne Muscular Dystrophy Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Duchenne Muscular Dystrophy Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Duchenne Muscular Dystrophy Sales (K Doses) by Type (2019-2024)
    Table 51. Global Duchenne Muscular Dystrophy Sales (K Doses) by Type (2025-2030)
    Table 52. Global Duchenne Muscular Dystrophy Sales Market Share by Type (2019-2024)
    Table 53. Global Duchenne Muscular Dystrophy Sales Market Share by Type (2025-2030)
    Table 54. Global Duchenne Muscular Dystrophy Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Duchenne Muscular Dystrophy Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Duchenne Muscular Dystrophy Revenue Market Share by Type (2019-2024)
    Table 57. Global Duchenne Muscular Dystrophy Revenue Market Share by Type (2025-2030)
    Table 58. Global Duchenne Muscular Dystrophy Price (USD/Dose) by Type (2019-2024)
    Table 59. Global Duchenne Muscular Dystrophy Price (USD/Dose) by Type (2025-2030)
    Table 60. Global Duchenne Muscular Dystrophy Sales (K Doses) by Application (2019-2024)
    Table 61. Global Duchenne Muscular Dystrophy Sales (K Doses) by Application (2025-2030)
    Table 62. Global Duchenne Muscular Dystrophy Sales Market Share by Application (2019-2024)
    Table 63. Global Duchenne Muscular Dystrophy Sales Market Share by Application (2025-2030)
    Table 64. Global Duchenne Muscular Dystrophy Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Duchenne Muscular Dystrophy Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Duchenne Muscular Dystrophy Revenue Market Share by Application (2019-2024)
    Table 67. Global Duchenne Muscular Dystrophy Revenue Market Share by Application (2025-2030)
    Table 68. Global Duchenne Muscular Dystrophy Price (USD/Dose) by Application (2019-2024)
    Table 69. Global Duchenne Muscular Dystrophy Price (USD/Dose) by Application (2025-2030)
    Table 70. Sarepta Therapeutics Corporation Information
    Table 71. Sarepta Therapeutics Description and Business Overview
    Table 72. Sarepta Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 73. Sarepta Therapeutics Duchenne Muscular Dystrophy Product
    Table 74. Sarepta Therapeutics Recent Developments/Updates
    Table 75. PTC Therapeutics Corporation Information
    Table 76. PTC Therapeutics Description and Business Overview
    Table 77. PTC Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 78. PTC Therapeutics Duchenne Muscular Dystrophy Product
    Table 79. PTC Therapeutics Recent Developments/Updates
    Table 80. Pfizer Corporation Information
    Table 81. Pfizer Description and Business Overview
    Table 82. Pfizer Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 83. Pfizer Duchenne Muscular Dystrophy Product
    Table 84. Pfizer Recent Developments/Updates
    Table 85. Bristol-Myers Squibb Corporation Information
    Table 86. Bristol-Myers Squibb Description and Business Overview
    Table 87. Bristol-Myers Squibb Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 88. Bristol-Myers Squibb Duchenne Muscular Dystrophy Product
    Table 89. Bristol-Myers Squibb Recent Developments/Updates
    Table 90. Italfarmaco Corporation Information
    Table 91. Italfarmaco Description and Business Overview
    Table 92. Italfarmaco Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 93. Italfarmaco Duchenne Muscular Dystrophy Product
    Table 94. Italfarmaco Recent Developments/Updates
    Table 95. Santhera Pharmaceuticals Corporation Information
    Table 96. Santhera Pharmaceuticals Description and Business Overview
    Table 97. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 98. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Product
    Table 99. Santhera Pharmaceuticals Recent Developments/Updates
    Table 100. Key Raw Materials Lists
    Table 101. Raw Materials Key Suppliers Lists
    Table 102. Duchenne Muscular Dystrophy Distributors List
    Table 103. Duchenne Muscular Dystrophy Customers List
    Table 104. Duchenne Muscular Dystrophy Market Trends
    Table 105. Duchenne Muscular Dystrophy Market Drivers
    Table 106. Duchenne Muscular Dystrophy Market Challenges
    Table 107. Duchenne Muscular Dystrophy Market Restraints
    Table 108. Research Programs/Design for This Report
    Table 109. Key Data Information from Secondary Sources
    Table 110. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Duchenne Muscular Dystrophy
    Figure 2. Global Duchenne Muscular Dystrophy Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Duchenne Muscular Dystrophy Market Share by Type in 2023 & 2030
    Figure 4. Exondys 51 Product Picture
    Figure 5. Emflaza Product Picture
    Figure 6. Translarna Product Picture
    Figure 7. Global Duchenne Muscular Dystrophy Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Duchenne Muscular Dystrophy Market Share by Application in 2023 & 2030
    Figure 9. Hospitals
    Figure 10. Clinics
    Figure 11. Home Care
    Figure 12. Global Duchenne Muscular Dystrophy Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Duchenne Muscular Dystrophy Market Size (2019-2030) & (US$ Million)
    Figure 14. Global Duchenne Muscular Dystrophy Sales (2019-2030) & (K Doses)
    Figure 15. Global Duchenne Muscular Dystrophy Average Price (USD/Dose) & (2019-2030)
    Figure 16. Duchenne Muscular Dystrophy Report Years Considered
    Figure 17. Duchenne Muscular Dystrophy Sales Share by Manufacturers in 2023
    Figure 18. Global Duchenne Muscular Dystrophy Revenue Share by Manufacturers in 2023
    Figure 19. The Global 5 and 10 Largest Duchenne Muscular Dystrophy Players: Market Share by Revenue in 2023
    Figure 20. Duchenne Muscular Dystrophy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 21. Global Duchenne Muscular Dystrophy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 22. North America Duchenne Muscular Dystrophy Sales Market Share by Country (2019-2030)
    Figure 23. North America Duchenne Muscular Dystrophy Revenue Market Share by Country (2019-2030)
    Figure 24. U.S. Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Canada Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Europe Duchenne Muscular Dystrophy Sales Market Share by Country (2019-2030)
    Figure 27. Europe Duchenne Muscular Dystrophy Revenue Market Share by Country (2019-2030)
    Figure 28. Germany Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. France Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. U.K. Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Italy Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Russia Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Duchenne Muscular Dystrophy Sales Market Share by Region (2019-2030)
    Figure 34. Asia Pacific Duchenne Muscular Dystrophy Revenue Market Share by Region (2019-2030)
    Figure 35. China Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Japan Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. South Korea Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. India Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Australia Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Taiwan Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Indonesia Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Thailand Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Malaysia Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Philippines Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Latin America Duchenne Muscular Dystrophy Sales Market Share by Country (2019-2030)
    Figure 46. Latin America Duchenne Muscular Dystrophy Revenue Market Share by Country (2019-2030)
    Figure 47. Mexico Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Brazil Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Argentina Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Duchenne Muscular Dystrophy Sales Market Share by Country (2019-2030)
    Figure 51. Middle East & Africa Duchenne Muscular Dystrophy Revenue Market Share by Country (2019-2030)
    Figure 52. Turkey Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. U.A.E Duchenne Muscular Dystrophy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Global Sales Market Share of Duchenne Muscular Dystrophy by Type (2019-2030)
    Figure 56. Global Revenue Market Share of Duchenne Muscular Dystrophy by Type (2019-2030)
    Figure 57. Global Duchenne Muscular Dystrophy Price (USD/Dose) by Type (2019-2030)
    Figure 58. Global Sales Market Share of Duchenne Muscular Dystrophy by Application (2019-2030)
    Figure 59. Global Revenue Market Share of Duchenne Muscular Dystrophy by Application (2019-2030)
    Figure 60. Global Duchenne Muscular Dystrophy Price (USD/Dose) by Application (2019-2030)
    Figure 61. Duchenne Muscular Dystrophy Value Chain
    Figure 62. Duchenne Muscular Dystrophy Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS